| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
1.012 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.012 |
Evidence |
|
| KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
RYR1 |
|
1.012 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
KCNB1 |
KCNB1: Potassium voltage-gated channel subfamily B member 1 |
1.012 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
1.012 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
1.012 |
Evidence |
|
| MAX |
MAX: Protein max |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
1.012 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CSK |
CSK: Tyrosine-protein kinase CSK |
1.012 |
Evidence |
O
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.012 |
Evidence |
|
| MAPK12 |
MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 |
SSH2 |
SSH2, KIAA1725, SSH2L: Protein phosphatase Slingshot homolog 2 |
1.012 |
Evidence |
|
| MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.012 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.012 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.012 |
Evidence |
|
| HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.012 |
Evidence |
|
| SVIL |
SVIL: Supervillin |
SEC24B |
SEC24B: Protein transport protein Sec24B |
1.012 |
Evidence |
|
| MMP7 |
MMP7, MPSL1, PUMP1: Matrilysin precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.012 |
Evidence |
|
| AHR |
AHR: Aryl hydrocarbon receptor precursor |
TFAP4 |
TFAP4: Transcription factor AP-4 |
1.012 |
Evidence |
|
| PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
STAT3 |
|
1.012 |
Evidence |
|
| MAPK13 |
MAPK13, PRKM13, SAPK4: Mitogen-activated protein kinase 13 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
1.012 |
Evidence |
|
| KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
1.012 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
STAT3 |
|
1.012 |
Evidence |
|
| MAX |
MAX: Protein max |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
1.012 |
Evidence |
|
| STAT3 |
|
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.012 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|